Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Enovis CORP Director's Dealing 2021

Nov 10, 2021

31808_dirs_2021-11-10_fd85c379-df80-4a94-b182-ad33362ca439.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Colfax CORP (CFX)
CIK: 0001420800
Period of Report: 2021-11-08

Reporting Person: Trerotola Matthew L. (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-08 Common stock, par value $.001 M 50000 $39.54 Acquired 355708 Direct
2021-11-08 Common stock, par value $.001 S 49890 $53.019 Disposed 305818 Direct
2021-11-08 Common stock, par value $.001 S 110 $53.815 Disposed 305708 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-11-08 Employee Stock Option (right to buy) $39.54 M 50000 Disposed 2022-07-23 Common stock, par value $.001 (50000) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.75 to $53.71, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

F3: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.76 to $53.82, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.

F4: The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 7/24/2015.